May 11, 2017 Columns by Laura Kolaczkowski The Importance of Caring for Caregivers “Coping with Caregiver Burnout When Caring for A Person with Neurodegenerative Disease: A Guide for Caregivers,” published in the April 2017 issue of the Archives for Physical Medicine and Rehabilitation, is intended…
April 27, 2017 Columns by Laura Kolaczkowski Crossing MS PATHS — and Taking a Stand for Patient Rights I knew it was only a matter of time before my MS neurologist would have MS PATHS available to collect clinical data from people who have agreed to participate. MS PATHS is an information- and biological sample-gathering…
April 20, 2017 Columns by Laura Kolaczkowski Canadian Neurologist Traboulsee Reflects on Today’s MS Options The American Academy of Neurology‘s (AAN) 2017 annual meeting will bring together physicians who practice in all areas of neurology, including our own multiple sclerosis (MS) specialists. In a recent interview with Anthony Traboulsee, MD,…
April 12, 2017 Columns by Laura Kolaczkowski RMS Patient Using Ocrevus in Trial: ‘I Feel Great’ Pamela Arterbridge is one of 70 people at Ohio State University’s Multiple Sclerosis Center taking part in the open-label part of a clinical trial for ocrelizumab, now best known as Ocrevus. She is a patient of Dr. Michael Racke,…
April 6, 2017 Columns by Laura Kolaczkowski Ohio State Neurologist Shares Insight About MS B-Cell Therapy Ocrevus A prominent neurologist, who was involved in early research into B-cell therapy, tells Multiple Sclerosis News Today about his positive experience of using ocrelizumab, now branded Ocrevus, with patients. Michael Racke, MD, Department of Neurology at The Ohio…
March 30, 2017 Columns by Laura Kolaczkowski Making Some Valid Points About Acupuncture and MS Have you ever used acupuncture? I have a number of times and would do so more often if it were a medical service covered by my insurance. Unfortunately, for now, most complementary treatments we have available to help with the…
March 9, 2017 Columns by Laura Kolaczkowski #ACTRIMS2017 – Neurologist Bourdette Questions ACTH Medicare Costs in Interview with MS News Today The sky-high costs to Medicare for prescriptions of the MS medication H.P. Acthar Gel, as reported in Multiple Sclerosis News Today were highlighted at the Americas…
March 2, 2017 Columns by Laura Kolaczkowski Which Improvements in Healthcare Would MS Advocates Like to See? I was in Washington, D.C. for a meeting, and had the opportunity to dine with some fellow multiple sclerosis advocates. I thought it might be of interest to get their take on the most pressing issues of…
March 1, 2017 Columns by Laura Kolaczkowski #ACTRIMS2017 – Gut Microbiome Gains Researchers’ Interest as Possible MS Therapy The role of the microbiome and its association with multiple sclerosis was the topic of several sessions and papers at the Americas Committee for Treatment and Research in Multiple Sclerosis (ACTRIMS) 2017 Forum. More than 800 researchers and clinicians…
February 28, 2017 News by Laura Kolaczkowski #ACTRIMS2017 – MS, the Gut and Probiotics Harold Weiner, MD, believes in using probiotics to help treat multiple sclerosis. He is such a believer that he did a presentation on the subject — “Probiotics in Multiple Sclerosis” — at the just-concluded Americas for Treatment and…
February 27, 2017 Columns by Laura Kolaczkowski #ACTRIMS2017 – Keynote Lecture Focused on Two Disease-Modifying Therapies Editor’s note: Columnist Laura Kolaczkowski writes from the Americas Committee for Treatment and Research in Multiple Sclerosis (ACTRIMS) 2017 Forum in Orlando, Fla., (Feb. 23-25). Two MS disease-modifying therapies, Ocrevus (ocrelizumab) and Rituxan (rituximab)…
February 24, 2017 Columns by Laura Kolaczkowski #ACTRIMS2017: Support for Vitamin D Supplements Grows Evidence supporting the use of Vitamin D for people with multiple sclerosis continues to grow but there remains many unanswered questions as well. Ellen Mowry, MD, Associate Professor of Neurology and Epidemiology at the Johns Hopkins MS Center,…
March 21, 2024 Columns by Benjamin Hofmeister I’m a disabled veteran, but sometimes it’s hard to explain